2-(4-diethylamino-phenylcarbamoyl)-1,2,3,4-tetrahydro-naphthalene-2-carboxylic acid | 827023-13-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 2-(4-diethylamino-phenylcarbamoyl)-1,2,3,4-tetrahydro-naphthalene-2-carboxylic acid
• 英文别名: 2-[[4-(diethylamino)phenyl]carbamoyl]-3,4-dihydro-1H-naphthalene-2-carboxylic acid
• CAS: 827023-13-2
• 化学式: C₂₂H₂₆N₂O₃
• 分子量: 366.46
• InChiKey: OFVFJMRYTBHHCC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  27
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  69.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(4-diethylamino-phenylcarbamoyl)-1,2,3,4-tetrahydro-naphthalene-2-carboxylic acid 、 异戊醇 在 O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate 、 三乙胺 作用下， 生成 3-methylbutyl 2-(((4-(diethylamino)phenyl)amino)carbonyl)-1,2,3,4-tetrahydronaphthalene-2-carboxylate
  参考文献：
  名称：

  Structure–activity relationship studies on tetralin carboxamide growth hormone secretagogue receptor antagonists

  摘要：

  The structure-activity relationship studies on a series of tetralin carboxamide growth hormone secretagogue receptor (GHS-R) antagonists are discussed. It was found that certain 2-alkoxycarbonylamino substituted tetralin carboxamides are potent, selective, and orally bioavailable GHS-R antagonists. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.02.026
• 作为产物：
  描述：

  1,2,3,4-四氢-2-萘甲酸甲酯 在 盐酸 、 lithium hydroxide 、 O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate 、 三乙胺 、 lithium diisopropyl amide 作用下， 以 1,4-二氧六环 为溶剂， 生成 2-(4-diethylamino-phenylcarbamoyl)-1,2,3,4-tetrahydro-naphthalene-2-carboxylic acid
  参考文献：
  名称：

  Structure–activity relationship studies on tetralin carboxamide growth hormone secretagogue receptor antagonists

  摘要：

  The structure-activity relationship studies on a series of tetralin carboxamide growth hormone secretagogue receptor (GHS-R) antagonists are discussed. It was found that certain 2-alkoxycarbonylamino substituted tetralin carboxamides are potent, selective, and orally bioavailable GHS-R antagonists. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.02.026

文献信息

• Tetraline derivatives as ghrelin receptor modulators
  申请人：Liu Bo

  公开号：US20050014794A1

  公开（公告）日：2005-01-20

  The present invention is related to compounds of formula (I), or a therapeutically suitable salt or prodrug thereof, the preparation of the compounds, compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders regulated by ghrelin including anorexia, cancer cachexia, eating disorders, age-related decline in body composition, weight gain, obesity, and diabetes mellitus.

  本发明涉及式(I)的化合物，或其在治疗上适宜的盐或前药，该化合物的制备，含有该化合物的组合物以及该化合物在预防或治疗由胃泌素调节的疾病中的应用，包括厌食症、癌症恶病质、进食障碍、与年龄相关的身体组成下降、体重增加、肥胖和糖尿病。
• US7115767B2
  申请人：——

  公开号：US7115767B2

  公开（公告）日：2006-10-03
• Structure–activity relationship studies on tetralin carboxamide growth hormone secretagogue receptor antagonists
  作者：Hongyu Zhao、Zhili Xin、Jyoti R. Patel、Lissa T.J. Nelson、Bo Liu、Bruce G. Szczepankiewicz、Verlyn G. Schaefer、H. Douglas Falls、Wiweka Kaszubska、Christine A. Collins、Hing L. Sham、Gang Liu

  DOI：10.1016/j.bmcl.2005.02.026

  日期：2005.4

  The structure-activity relationship studies on a series of tetralin carboxamide growth hormone secretagogue receptor (GHS-R) antagonists are discussed. It was found that certain 2-alkoxycarbonylamino substituted tetralin carboxamides are potent, selective, and orally bioavailable GHS-R antagonists. (c) 2005 Elsevier Ltd. All rights reserved.